Medical Care

Global Integrated Drug Discovery Service Market Research Report 2025

The global market for Integrated Drug Discovery Service was valued at US$ 30420 million in the year 2024 and is projected to reach a revised size of US$ 72920 million by 2031, growing at a CAGR of 13.5% during the forecast period.
Integrated Drug Discovery Service (IDDS) refers to a comprehensive approach to drug discovery that combines multiple expertise and technologies under one roof, streamlining the entire process from target identification to clinical development. It contrasts with the traditional, more fragmented approach where different stages of drug discovery are often handled by separate companies or research groups.
The Integrated Drug Discovery Service market is experiencing strong and sustained growth, fueled by several key factors:
Market Drivers:
Rising demand for new drugs: The global pharmaceutical industry faces constant pressure to develop new and effective drugs for various diseases. Integrated drug discovery services provide a comprehensive solution, streamlining the drug discovery process and accelerating the development of new therapies.
Focus on efficiency and cost-effectiveness: Pharmaceutical companies are looking for ways to reduce the high costs and risks associated with traditional drug discovery. Integrated services offer a more efficient and cost-effective approach by combining various expertise and technologies under one roof.
Technological advancements: Advancements in areas like artificial intelligence, high-throughput screening, and computational biology are transforming the drug discovery landscape, making integrated services even more powerful and efficient.
Growing complexity of drug targets: Modern drug targets are often complex and require a multidisciplinary approach. Integrated services offer access to a wider range of expertise and technologies to tackle these challenges.
Increased outsourcing: Many pharmaceutical companies are choosing to outsource some or all of their drug discovery efforts to specialized CROs (Contract Research Organizations) offering integrated services, allowing them to focus on core competencies and reduce internal resources.
Market Challenges:
High cost of entry: Setting up and maintaining integrated drug discovery capabilities requires significant investment in infrastructure, technology, and personnel, which can be a barrier for smaller players.
Competition: The market is becoming increasingly competitive, with established CROs and emerging startups vying for market share.
Complexities in managing partnerships: Effective collaboration and communication between pharmaceutical companies and integrated service providers are crucial for success, but managing large and complex partnerships can be challenging.
Regulatory hurdles: Stringent regulations in the pharmaceutical industry require strict compliance with quality and safety standards, which can increase the complexity and cost of providing integrated services.
Integration of data and workflows: Integrating data generated from different platforms and technologies within the integrated drug discovery process requires sophisticated data management strategies and expertise.
Overall, the Integrated Drug Discovery Service market is a dynamic and promising sector with significant growth potential. Technological advancements, an increasing focus on efficiency, and the rising demand for new drugs are driving this market forward. However, challenges like managing complex partnerships, navigating regulatory hurdles, and integrating data and workflows need to be addressed to ensure continued success.
This report aims to provide a comprehensive presentation of the global market for Integrated Drug Discovery Service, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Integrated Drug Discovery Service.
The Integrated Drug Discovery Service market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Integrated Drug Discovery Service market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Integrated Drug Discovery Service companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Syngene
Eurofins
Charles River
Evotec
BioAscent
Sygnature Discovery
Jubilant Biosys
Charnwood Molecular
Domainex
Pharmaron
Dalton Pharma Services
Selvita
Metrion Biosciences
WuXi AppTec
Malvern Panalytical
Hitgen
BioDuro
Curia Global
Taros Chemicals
Symeres
Aragen Life Sciences
Segment by Type
Ligand Based Drug Discovery
Structure Based Drug Discovery
Others
Segment by Application
Biotech and Pharmaceutical Companies
Academic Institution
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Integrated Drug Discovery Service company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Integrated Drug Discovery Service Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Ligand Based Drug Discovery
1.2.3 Structure Based Drug Discovery
1.2.4 Others
1.3 Market by Application
1.3.1 Global Integrated Drug Discovery Service Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Biotech and Pharmaceutical Companies
1.3.3 Academic Institution
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Integrated Drug Discovery Service Market Perspective (2020-2031)
2.2 Global Integrated Drug Discovery Service Growth Trends by Region
2.2.1 Global Integrated Drug Discovery Service Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Integrated Drug Discovery Service Historic Market Size by Region (2020-2025)
2.2.3 Integrated Drug Discovery Service Forecasted Market Size by Region (2026-2031)
2.3 Integrated Drug Discovery Service Market Dynamics
2.3.1 Integrated Drug Discovery Service Industry Trends
2.3.2 Integrated Drug Discovery Service Market Drivers
2.3.3 Integrated Drug Discovery Service Market Challenges
2.3.4 Integrated Drug Discovery Service Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Integrated Drug Discovery Service Players by Revenue
3.1.1 Global Top Integrated Drug Discovery Service Players by Revenue (2020-2025)
3.1.2 Global Integrated Drug Discovery Service Revenue Market Share by Players (2020-2025)
3.2 Global Integrated Drug Discovery Service Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Integrated Drug Discovery Service Revenue
3.4 Global Integrated Drug Discovery Service Market Concentration Ratio
3.4.1 Global Integrated Drug Discovery Service Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Integrated Drug Discovery Service Revenue in 2024
3.5 Global Key Players of Integrated Drug Discovery Service Head office and Area Served
3.6 Global Key Players of Integrated Drug Discovery Service, Product and Application
3.7 Global Key Players of Integrated Drug Discovery Service, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Integrated Drug Discovery Service Breakdown Data by Type
4.1 Global Integrated Drug Discovery Service Historic Market Size by Type (2020-2025)
4.2 Global Integrated Drug Discovery Service Forecasted Market Size by Type (2026-2031)
5 Integrated Drug Discovery Service Breakdown Data by Application
5.1 Global Integrated Drug Discovery Service Historic Market Size by Application (2020-2025)
5.2 Global Integrated Drug Discovery Service Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Integrated Drug Discovery Service Market Size (2020-2031)
6.2 North America Integrated Drug Discovery Service Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Integrated Drug Discovery Service Market Size by Country (2020-2025)
6.4 North America Integrated Drug Discovery Service Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Integrated Drug Discovery Service Market Size (2020-2031)
7.2 Europe Integrated Drug Discovery Service Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Integrated Drug Discovery Service Market Size by Country (2020-2025)
7.4 Europe Integrated Drug Discovery Service Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Integrated Drug Discovery Service Market Size (2020-2031)
8.2 Asia-Pacific Integrated Drug Discovery Service Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Integrated Drug Discovery Service Market Size by Region (2020-2025)
8.4 Asia-Pacific Integrated Drug Discovery Service Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Integrated Drug Discovery Service Market Size (2020-2031)
9.2 Latin America Integrated Drug Discovery Service Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Integrated Drug Discovery Service Market Size by Country (2020-2025)
9.4 Latin America Integrated Drug Discovery Service Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Integrated Drug Discovery Service Market Size (2020-2031)
10.2 Middle East & Africa Integrated Drug Discovery Service Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Integrated Drug Discovery Service Market Size by Country (2020-2025)
10.4 Middle East & Africa Integrated Drug Discovery Service Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Syngene
11.1.1 Syngene Company Details
11.1.2 Syngene Business Overview
11.1.3 Syngene Integrated Drug Discovery Service Introduction
11.1.4 Syngene Revenue in Integrated Drug Discovery Service Business (2020-2025)
11.1.5 Syngene Recent Development
11.2 Eurofins
11.2.1 Eurofins Company Details
11.2.2 Eurofins Business Overview
11.2.3 Eurofins Integrated Drug Discovery Service Introduction
11.2.4 Eurofins Revenue in Integrated Drug Discovery Service Business (2020-2025)
11.2.5 Eurofins Recent Development
11.3 Charles River
11.3.1 Charles River Company Details
11.3.2 Charles River Business Overview
11.3.3 Charles River Integrated Drug Discovery Service Introduction
11.3.4 Charles River Revenue in Integrated Drug Discovery Service Business (2020-2025)
11.3.5 Charles River Recent Development
11.4 Evotec
11.4.1 Evotec Company Details
11.4.2 Evotec Business Overview
11.4.3 Evotec Integrated Drug Discovery Service Introduction
11.4.4 Evotec Revenue in Integrated Drug Discovery Service Business (2020-2025)
11.4.5 Evotec Recent Development
11.5 BioAscent
11.5.1 BioAscent Company Details
11.5.2 BioAscent Business Overview
11.5.3 BioAscent Integrated Drug Discovery Service Introduction
11.5.4 BioAscent Revenue in Integrated Drug Discovery Service Business (2020-2025)
11.5.5 BioAscent Recent Development
11.6 Sygnature Discovery
11.6.1 Sygnature Discovery Company Details
11.6.2 Sygnature Discovery Business Overview
11.6.3 Sygnature Discovery Integrated Drug Discovery Service Introduction
11.6.4 Sygnature Discovery Revenue in Integrated Drug Discovery Service Business (2020-2025)
11.6.5 Sygnature Discovery Recent Development
11.7 Jubilant Biosys
11.7.1 Jubilant Biosys Company Details
11.7.2 Jubilant Biosys Business Overview
11.7.3 Jubilant Biosys Integrated Drug Discovery Service Introduction
11.7.4 Jubilant Biosys Revenue in Integrated Drug Discovery Service Business (2020-2025)
11.7.5 Jubilant Biosys Recent Development
11.8 Charnwood Molecular
11.8.1 Charnwood Molecular Company Details
11.8.2 Charnwood Molecular Business Overview
11.8.3 Charnwood Molecular Integrated Drug Discovery Service Introduction
11.8.4 Charnwood Molecular Revenue in Integrated Drug Discovery Service Business (2020-2025)
11.8.5 Charnwood Molecular Recent Development
11.9 Domainex
11.9.1 Domainex Company Details
11.9.2 Domainex Business Overview
11.9.3 Domainex Integrated Drug Discovery Service Introduction
11.9.4 Domainex Revenue in Integrated Drug Discovery Service Business (2020-2025)
11.9.5 Domainex Recent Development
11.10 Pharmaron
11.10.1 Pharmaron Company Details
11.10.2 Pharmaron Business Overview
11.10.3 Pharmaron Integrated Drug Discovery Service Introduction
11.10.4 Pharmaron Revenue in Integrated Drug Discovery Service Business (2020-2025)
11.10.5 Pharmaron Recent Development
11.11 Dalton Pharma Services
11.11.1 Dalton Pharma Services Company Details
11.11.2 Dalton Pharma Services Business Overview
11.11.3 Dalton Pharma Services Integrated Drug Discovery Service Introduction
11.11.4 Dalton Pharma Services Revenue in Integrated Drug Discovery Service Business (2020-2025)
11.11.5 Dalton Pharma Services Recent Development
11.12 Selvita
11.12.1 Selvita Company Details
11.12.2 Selvita Business Overview
11.12.3 Selvita Integrated Drug Discovery Service Introduction
11.12.4 Selvita Revenue in Integrated Drug Discovery Service Business (2020-2025)
11.12.5 Selvita Recent Development
11.13 Metrion Biosciences
11.13.1 Metrion Biosciences Company Details
11.13.2 Metrion Biosciences Business Overview
11.13.3 Metrion Biosciences Integrated Drug Discovery Service Introduction
11.13.4 Metrion Biosciences Revenue in Integrated Drug Discovery Service Business (2020-2025)
11.13.5 Metrion Biosciences Recent Development
11.14 WuXi AppTec
11.14.1 WuXi AppTec Company Details
11.14.2 WuXi AppTec Business Overview
11.14.3 WuXi AppTec Integrated Drug Discovery Service Introduction
11.14.4 WuXi AppTec Revenue in Integrated Drug Discovery Service Business (2020-2025)
11.14.5 WuXi AppTec Recent Development
11.15 Malvern Panalytical
11.15.1 Malvern Panalytical Company Details
11.15.2 Malvern Panalytical Business Overview
11.15.3 Malvern Panalytical Integrated Drug Discovery Service Introduction
11.15.4 Malvern Panalytical Revenue in Integrated Drug Discovery Service Business (2020-2025)
11.15.5 Malvern Panalytical Recent Development
11.16 Hitgen
11.16.1 Hitgen Company Details
11.16.2 Hitgen Business Overview
11.16.3 Hitgen Integrated Drug Discovery Service Introduction
11.16.4 Hitgen Revenue in Integrated Drug Discovery Service Business (2020-2025)
11.16.5 Hitgen Recent Development
11.17 BioDuro
11.17.1 BioDuro Company Details
11.17.2 BioDuro Business Overview
11.17.3 BioDuro Integrated Drug Discovery Service Introduction
11.17.4 BioDuro Revenue in Integrated Drug Discovery Service Business (2020-2025)
11.17.5 BioDuro Recent Development
11.18 Curia Global
11.18.1 Curia Global Company Details
11.18.2 Curia Global Business Overview
11.18.3 Curia Global Integrated Drug Discovery Service Introduction
11.18.4 Curia Global Revenue in Integrated Drug Discovery Service Business (2020-2025)
11.18.5 Curia Global Recent Development
11.19 Taros Chemicals
11.19.1 Taros Chemicals Company Details
11.19.2 Taros Chemicals Business Overview
11.19.3 Taros Chemicals Integrated Drug Discovery Service Introduction
11.19.4 Taros Chemicals Revenue in Integrated Drug Discovery Service Business (2020-2025)
11.19.5 Taros Chemicals Recent Development
11.20 Symeres
11.20.1 Symeres Company Details
11.20.2 Symeres Business Overview
11.20.3 Symeres Integrated Drug Discovery Service Introduction
11.20.4 Symeres Revenue in Integrated Drug Discovery Service Business (2020-2025)
11.20.5 Symeres Recent Development
11.21 Aragen Life Sciences
11.21.1 Aragen Life Sciences Company Details
11.21.2 Aragen Life Sciences Business Overview
11.21.3 Aragen Life Sciences Integrated Drug Discovery Service Introduction
11.21.4 Aragen Life Sciences Revenue in Integrated Drug Discovery Service Business (2020-2025)
11.21.5 Aragen Life Sciences Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Integrated Drug Discovery Service Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Ligand Based Drug Discovery
Table 3. Key Players of Structure Based Drug Discovery
Table 4. Key Players of Others
Table 5. Global Integrated Drug Discovery Service Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Integrated Drug Discovery Service Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 7. Global Integrated Drug Discovery Service Market Size by Region (2020-2025) & (US$ Million)
Table 8. Global Integrated Drug Discovery Service Market Share by Region (2020-2025)
Table 9. Global Integrated Drug Discovery Service Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 10. Global Integrated Drug Discovery Service Market Share by Region (2026-2031)
Table 11. Integrated Drug Discovery Service Market Trends
Table 12. Integrated Drug Discovery Service Market Drivers
Table 13. Integrated Drug Discovery Service Market Challenges
Table 14. Integrated Drug Discovery Service Market Restraints
Table 15. Global Integrated Drug Discovery Service Revenue by Players (2020-2025) & (US$ Million)
Table 16. Global Integrated Drug Discovery Service Market Share by Players (2020-2025)
Table 17. Global Top Integrated Drug Discovery Service Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Integrated Drug Discovery Service as of 2024)
Table 18. Ranking of Global Top Integrated Drug Discovery Service Companies by Revenue (US$ Million) in 2024
Table 19. Global 5 Largest Players Market Share by Integrated Drug Discovery Service Revenue (CR5 and HHI) & (2020-2025)
Table 20. Global Key Players of Integrated Drug Discovery Service, Headquarters and Area Served
Table 21. Global Key Players of Integrated Drug Discovery Service, Product and Application
Table 22. Global Key Players of Integrated Drug Discovery Service, Date of Enter into This Industry
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Integrated Drug Discovery Service Market Size by Type (2020-2025) & (US$ Million)
Table 25. Global Integrated Drug Discovery Service Revenue Market Share by Type (2020-2025)
Table 26. Global Integrated Drug Discovery Service Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 27. Global Integrated Drug Discovery Service Revenue Market Share by Type (2026-2031)
Table 28. Global Integrated Drug Discovery Service Market Size by Application (2020-2025) & (US$ Million)
Table 29. Global Integrated Drug Discovery Service Revenue Market Share by Application (2020-2025)
Table 30. Global Integrated Drug Discovery Service Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 31. Global Integrated Drug Discovery Service Revenue Market Share by Application (2026-2031)
Table 32. North America Integrated Drug Discovery Service Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 33. North America Integrated Drug Discovery Service Market Size by Country (2020-2025) & (US$ Million)
Table 34. North America Integrated Drug Discovery Service Market Size by Country (2026-2031) & (US$ Million)
Table 35. Europe Integrated Drug Discovery Service Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 36. Europe Integrated Drug Discovery Service Market Size by Country (2020-2025) & (US$ Million)
Table 37. Europe Integrated Drug Discovery Service Market Size by Country (2026-2031) & (US$ Million)
Table 38. Asia-Pacific Integrated Drug Discovery Service Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 39. Asia-Pacific Integrated Drug Discovery Service Market Size by Region (2020-2025) & (US$ Million)
Table 40. Asia-Pacific Integrated Drug Discovery Service Market Size by Region (2026-2031) & (US$ Million)
Table 41. Latin America Integrated Drug Discovery Service Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 42. Latin America Integrated Drug Discovery Service Market Size by Country (2020-2025) & (US$ Million)
Table 43. Latin America Integrated Drug Discovery Service Market Size by Country (2026-2031) & (US$ Million)
Table 44. Middle East & Africa Integrated Drug Discovery Service Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 45. Middle East & Africa Integrated Drug Discovery Service Market Size by Country (2020-2025) & (US$ Million)
Table 46. Middle East & Africa Integrated Drug Discovery Service Market Size by Country (2026-2031) & (US$ Million)
Table 47. Syngene Company Details
Table 48. Syngene Business Overview
Table 49. Syngene Integrated Drug Discovery Service Product
Table 50. Syngene Revenue in Integrated Drug Discovery Service Business (2020-2025) & (US$ Million)
Table 51. Syngene Recent Development
Table 52. Eurofins Company Details
Table 53. Eurofins Business Overview
Table 54. Eurofins Integrated Drug Discovery Service Product
Table 55. Eurofins Revenue in Integrated Drug Discovery Service Business (2020-2025) & (US$ Million)
Table 56. Eurofins Recent Development
Table 57. Charles River Company Details
Table 58. Charles River Business Overview
Table 59. Charles River Integrated Drug Discovery Service Product
Table 60. Charles River Revenue in Integrated Drug Discovery Service Business (2020-2025) & (US$ Million)
Table 61. Charles River Recent Development
Table 62. Evotec Company Details
Table 63. Evotec Business Overview
Table 64. Evotec Integrated Drug Discovery Service Product
Table 65. Evotec Revenue in Integrated Drug Discovery Service Business (2020-2025) & (US$ Million)
Table 66. Evotec Recent Development
Table 67. BioAscent Company Details
Table 68. BioAscent Business Overview
Table 69. BioAscent Integrated Drug Discovery Service Product
Table 70. BioAscent Revenue in Integrated Drug Discovery Service Business (2020-2025) & (US$ Million)
Table 71. BioAscent Recent Development
Table 72. Sygnature Discovery Company Details
Table 73. Sygnature Discovery Business Overview
Table 74. Sygnature Discovery Integrated Drug Discovery Service Product
Table 75. Sygnature Discovery Revenue in Integrated Drug Discovery Service Business (2020-2025) & (US$ Million)
Table 76. Sygnature Discovery Recent Development
Table 77. Jubilant Biosys Company Details
Table 78. Jubilant Biosys Business Overview
Table 79. Jubilant Biosys Integrated Drug Discovery Service Product
Table 80. Jubilant Biosys Revenue in Integrated Drug Discovery Service Business (2020-2025) & (US$ Million)
Table 81. Jubilant Biosys Recent Development
Table 82. Charnwood Molecular Company Details
Table 83. Charnwood Molecular Business Overview
Table 84. Charnwood Molecular Integrated Drug Discovery Service Product
Table 85. Charnwood Molecular Revenue in Integrated Drug Discovery Service Business (2020-2025) & (US$ Million)
Table 86. Charnwood Molecular Recent Development
Table 87. Domainex Company Details
Table 88. Domainex Business Overview
Table 89. Domainex Integrated Drug Discovery Service Product
Table 90. Domainex Revenue in Integrated Drug Discovery Service Business (2020-2025) & (US$ Million)
Table 91. Domainex Recent Development
Table 92. Pharmaron Company Details
Table 93. Pharmaron Business Overview
Table 94. Pharmaron Integrated Drug Discovery Service Product
Table 95. Pharmaron Revenue in Integrated Drug Discovery Service Business (2020-2025) & (US$ Million)
Table 96. Pharmaron Recent Development
Table 97. Dalton Pharma Services Company Details
Table 98. Dalton Pharma Services Business Overview
Table 99. Dalton Pharma Services Integrated Drug Discovery Service Product
Table 100. Dalton Pharma Services Revenue in Integrated Drug Discovery Service Business (2020-2025) & (US$ Million)
Table 101. Dalton Pharma Services Recent Development
Table 102. Selvita Company Details
Table 103. Selvita Business Overview
Table 104. Selvita Integrated Drug Discovery Service Product
Table 105. Selvita Revenue in Integrated Drug Discovery Service Business (2020-2025) & (US$ Million)
Table 106. Selvita Recent Development
Table 107. Metrion Biosciences Company Details
Table 108. Metrion Biosciences Business Overview
Table 109. Metrion Biosciences Integrated Drug Discovery Service Product
Table 110. Metrion Biosciences Revenue in Integrated Drug Discovery Service Business (2020-2025) & (US$ Million)
Table 111. Metrion Biosciences Recent Development
Table 112. WuXi AppTec Company Details
Table 113. WuXi AppTec Business Overview
Table 114. WuXi AppTec Integrated Drug Discovery Service Product
Table 115. WuXi AppTec Revenue in Integrated Drug Discovery Service Business (2020-2025) & (US$ Million)
Table 116. WuXi AppTec Recent Development
Table 117. Malvern Panalytical Company Details
Table 118. Malvern Panalytical Business Overview
Table 119. Malvern Panalytical Integrated Drug Discovery Service Product
Table 120. Malvern Panalytical Revenue in Integrated Drug Discovery Service Business (2020-2025) & (US$ Million)
Table 121. Malvern Panalytical Recent Development
Table 122. Hitgen Company Details
Table 123. Hitgen Business Overview
Table 124. Hitgen Integrated Drug Discovery Service Product
Table 125. Hitgen Revenue in Integrated Drug Discovery Service Business (2020-2025) & (US$ Million)
Table 126. Hitgen Recent Development
Table 127. BioDuro Company Details
Table 128. BioDuro Business Overview
Table 129. BioDuro Integrated Drug Discovery Service Product
Table 130. BioDuro Revenue in Integrated Drug Discovery Service Business (2020-2025) & (US$ Million)
Table 131. BioDuro Recent Development
Table 132. Curia Global Company Details
Table 133. Curia Global Business Overview
Table 134. Curia Global Integrated Drug Discovery Service Product
Table 135. Curia Global Revenue in Integrated Drug Discovery Service Business (2020-2025) & (US$ Million)
Table 136. Curia Global Recent Development
Table 137. Taros Chemicals Company Details
Table 138. Taros Chemicals Business Overview
Table 139. Taros Chemicals Integrated Drug Discovery Service Product
Table 140. Taros Chemicals Revenue in Integrated Drug Discovery Service Business (2020-2025) & (US$ Million)
Table 141. Taros Chemicals Recent Development
Table 142. Symeres Company Details
Table 143. Symeres Business Overview
Table 144. Symeres Integrated Drug Discovery Service Product
Table 145. Symeres Revenue in Integrated Drug Discovery Service Business (2020-2025) & (US$ Million)
Table 146. Symeres Recent Development
Table 147. Aragen Life Sciences Company Details
Table 148. Aragen Life Sciences Business Overview
Table 149. Aragen Life Sciences Integrated Drug Discovery Service Product
Table 150. Aragen Life Sciences Revenue in Integrated Drug Discovery Service Business (2020-2025) & (US$ Million)
Table 151. Aragen Life Sciences Recent Development
Table 152. Research Programs/Design for This Report
Table 153. Key Data Information from Secondary Sources
Table 154. Key Data Information from Primary Sources
Table 155. Authors List of This Report


List of Figures
Figure 1. Integrated Drug Discovery Service Picture
Figure 2. Global Integrated Drug Discovery Service Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Integrated Drug Discovery Service Market Share by Type: 2024 VS 2031
Figure 4. Ligand Based Drug Discovery Features
Figure 5. Structure Based Drug Discovery Features
Figure 6. Others Features
Figure 7. Global Integrated Drug Discovery Service Market Size by Application (2020-2031) & (US$ Million)
Figure 8. Global Integrated Drug Discovery Service Market Share by Application: 2024 VS 2031
Figure 9. Biotech and Pharmaceutical Companies Case Studies
Figure 10. Academic Institution Case Studies
Figure 11. Others Case Studies
Figure 12. Integrated Drug Discovery Service Report Years Considered
Figure 13. Global Integrated Drug Discovery Service Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 14. Global Integrated Drug Discovery Service Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 15. Global Integrated Drug Discovery Service Market Share by Region: 2024 VS 2031
Figure 16. Global Integrated Drug Discovery Service Market Share by Players in 2024
Figure 17. Global Top Integrated Drug Discovery Service Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Integrated Drug Discovery Service as of 2024)
Figure 18. The Top 10 and 5 Players Market Share by Integrated Drug Discovery Service Revenue in 2024
Figure 19. North America Integrated Drug Discovery Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 20. North America Integrated Drug Discovery Service Market Share by Country (2020-2031)
Figure 21. United States Integrated Drug Discovery Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. Canada Integrated Drug Discovery Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Europe Integrated Drug Discovery Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Europe Integrated Drug Discovery Service Market Share by Country (2020-2031)
Figure 25. Germany Integrated Drug Discovery Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. France Integrated Drug Discovery Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. U.K. Integrated Drug Discovery Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Italy Integrated Drug Discovery Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Russia Integrated Drug Discovery Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Nordic Countries Integrated Drug Discovery Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Asia-Pacific Integrated Drug Discovery Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Asia-Pacific Integrated Drug Discovery Service Market Share by Region (2020-2031)
Figure 33. China Integrated Drug Discovery Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Japan Integrated Drug Discovery Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. South Korea Integrated Drug Discovery Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Southeast Asia Integrated Drug Discovery Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. India Integrated Drug Discovery Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Australia Integrated Drug Discovery Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Latin America Integrated Drug Discovery Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Latin America Integrated Drug Discovery Service Market Share by Country (2020-2031)
Figure 41. Mexico Integrated Drug Discovery Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Brazil Integrated Drug Discovery Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Middle East & Africa Integrated Drug Discovery Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Middle East & Africa Integrated Drug Discovery Service Market Share by Country (2020-2031)
Figure 45. Turkey Integrated Drug Discovery Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Saudi Arabia Integrated Drug Discovery Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. UAE Integrated Drug Discovery Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. Syngene Revenue Growth Rate in Integrated Drug Discovery Service Business (2020-2025)
Figure 49. Eurofins Revenue Growth Rate in Integrated Drug Discovery Service Business (2020-2025)
Figure 50. Charles River Revenue Growth Rate in Integrated Drug Discovery Service Business (2020-2025)
Figure 51. Evotec Revenue Growth Rate in Integrated Drug Discovery Service Business (2020-2025)
Figure 52. BioAscent Revenue Growth Rate in Integrated Drug Discovery Service Business (2020-2025)
Figure 53. Sygnature Discovery Revenue Growth Rate in Integrated Drug Discovery Service Business (2020-2025)
Figure 54. Jubilant Biosys Revenue Growth Rate in Integrated Drug Discovery Service Business (2020-2025)
Figure 55. Charnwood Molecular Revenue Growth Rate in Integrated Drug Discovery Service Business (2020-2025)
Figure 56. Domainex Revenue Growth Rate in Integrated Drug Discovery Service Business (2020-2025)
Figure 57. Pharmaron Revenue Growth Rate in Integrated Drug Discovery Service Business (2020-2025)
Figure 58. Dalton Pharma Services Revenue Growth Rate in Integrated Drug Discovery Service Business (2020-2025)
Figure 59. Selvita Revenue Growth Rate in Integrated Drug Discovery Service Business (2020-2025)
Figure 60. Metrion Biosciences Revenue Growth Rate in Integrated Drug Discovery Service Business (2020-2025)
Figure 61. WuXi AppTec Revenue Growth Rate in Integrated Drug Discovery Service Business (2020-2025)
Figure 62. Malvern Panalytical Revenue Growth Rate in Integrated Drug Discovery Service Business (2020-2025)
Figure 63. Hitgen Revenue Growth Rate in Integrated Drug Discovery Service Business (2020-2025)
Figure 64. BioDuro Revenue Growth Rate in Integrated Drug Discovery Service Business (2020-2025)
Figure 65. Curia Global Revenue Growth Rate in Integrated Drug Discovery Service Business (2020-2025)
Figure 66. Taros Chemicals Revenue Growth Rate in Integrated Drug Discovery Service Business (2020-2025)
Figure 67. Symeres Revenue Growth Rate in Integrated Drug Discovery Service Business (2020-2025)
Figure 68. Aragen Life Sciences Revenue Growth Rate in Integrated Drug Discovery Service Business (2020-2025)
Figure 69. Bottom-up and Top-down Approaches for This Report
Figure 70. Data Triangulation
Figure 71. Key Executives Interviewed
Choose Your Edition
Add to cart

Our team would be happy to assist you with your queries.

Contact us

About us

Accurate data, The latest market trends, And deeper research directions.

Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals

Latest reports

Useful links

Our Contacts

Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China

(+86) 159 1069 5232

sales@hengceresearch.com
hengceresearch.com

Allow cookies